Argen-X (ARGX)

362.70
+5.20(+1.45%)
  • Volume:
    86,684
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    354.70 - 363.00
  • Type:Equity
  • Market:Belgium
  • ISIN:NL0010832176

ARGX Overview

Prev. Close
357.5
Day's Range
354.7-363
Revenue
500.09M
Open
358.1
52 wk Range
224.1-363
EPS
-10.99
Volume
86,684
Market Cap
19.82B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
86,006
P/E Ratio
-
Beta
0.68
1-Year Change
38.22%
Shares Outstanding
54,633,958
Next Earnings Date
27 Jul 2022
What is your sentiment on Argen-X?
or
Market is currently closed. Voting is open during market hours.

Argen-X News

Argen-X Company Profile

Argen-X Company Profile

Employees
650
Market
Belgium

argenx SE, formerly arGEN X BV, is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. It includes: ARGX-110, an antibody for heme malignancies and solid tumors, which modulates functions of tumor such as cell proliferation and survival; ARGX-111, an antagonist of c-Met, a receptor tyrosine kinase involved in cell proliferation, angiogenesis and metastasis in multiple solid tumors; ARGX-112, an antigen which targets atopic dermatitis by neutralization of IL-20 and IL-22 (interleukin) mediated signaling through blockade of their common receptor, among others.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy